Article
Identification of two novel mutations in human acute myeloid leukemia cases.
Leukemia & lymphoma - 1 Feb 2021
O'Brien Gráinne, Zyla Joanna, Manola Kalliopi N, Pagoni Maria N, Polanska Joanna, Badie Christophe
Abstract excerpt
Acute myeloid leukemia (AML) is an aggressive cancer that progresses rapidly with a poor prognosis. Cytogenetic analysis provides the most accurate determination of diagnosis and prognosis however, about 42-48% of AML patients have a cytogenetically normal karyotype. Genetic analysis can provide further information and the identification of new mutations could result in improved risk stratification, prognosis and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
